Aqua Metals, Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 8, 2025 and accepted by EDGAR at May 8, 2025, 20:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $0 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $724.0k | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$8.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $403.0k | us-gaap:InterestExpenseNonoperating |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$8.3m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$1.03 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | −$2.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $289.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-03-31 | $1.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $2.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $18.1m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $7.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $8.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $9.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-25-015480. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.